"Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Ruxolitinib cream is a topical formulation of ruxolitinib, a Janus kinase (JAK) 1/JAK2 inhibitor. Click to show full abstract

Ruxolitinib cream is a topical formulation of ruxolitinib, a Janus kinase (JAK) 1/JAK2 inhibitor.

Keywords: ruxolitinib; ruxolitinib cream; pruritus reduction; rapid pruritus; reduction ruxolitinib

Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended